Dennis Nurjadi
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 35
-
- Antibiotic Use and Resistance 12
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 22
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 32
- Endocrinology top 5%
- Vibrio bacteria research studies 7
-
- Antibiotics Pharmacokinetics and Efficacy 14
-
- Bacterial biofilms and quorum sensing 11
-
- Streptococcal Infections and Treatments 10
Dennis Nurjadi
75 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 347
- Applied Microbiology and Biotechnology 93
- Clinical Biochemistry 271
- Infectious Diseases 570
- Endocrinology 109
Countries citing papers authored by Dennis Nurjadi
This map shows the geographic impact of Dennis Nurjadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Nurjadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Nurjadi more than expected).
Fields of papers citing papers by Dennis Nurjadi
This network shows the impact of papers produced by Dennis Nurjadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Nurjadi. The network helps show where Dennis Nurjadi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dennis Nurjadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 8 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 0 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 16 | |
| 12 | 2020 | 12 | |
| 13 | 2020 | 14 | |
| 14 | 2019 | 11 | |
| 15 | 2018 | 16 | |
| 16 | 2018 | 33 | |
| 17 | 2015 | 31 | |
| 18 | 2015 | 66 | |
| 19 | 2012 | 30 | |
| 20 | 2012 | 28 |
About Dennis Nurjadi
Dennis Nurjadi is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 85 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (35 papers), Antimicrobial Resistance in Staphylococcus (32 papers), Bacterial Identification and Susceptibility Testing (22 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Use and Resistance (12 papers), Bacterial biofilms and quorum sensing (11 papers), Streptococcal Infections and Treatments (10 papers) and Vibrio bacteria research studies (7 papers). The work is most often cited by research in Molecular Medicine (347 citations), Applied Microbiology and Biotechnology (93 citations) and Clinical Biochemistry (271 citations). Dennis Nurjadi has collaborated with scholars based in Germany, Vietnam and Gabon. Frequent co-authors include Philipp Zanger, Klaus Heeg, Sébastien Boutin, Peter G. Kremsner, Sabrina Klein, Stefan Zimmermann, Christiane Wolz, Frank P. Mockenhaupt, Nico T. Mutters and Tatjana Eigenbrod. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Clinical Microbiology and Infection, Clinical Infectious Diseases and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.